The Weekly Litigation News Digest is now live. Subscribe now

5-Methoxy-N,N-Dimethyltryptamine (5-Meo-Dmt) For Treating Depression - EP3927337

The patent EP3927337 was granted to GH Research on Mar 20, 2024. The application was originally filed on Feb 24, 2020 under application number EP20710059A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3927337

GH RESEARCH
Application Number
EP20710059A
Filing Date
Feb 24, 2020
Status
Granted And Under Opposition
Jan 12, 2024
Publication Date
Mar 20, 2024
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

STRAWMANNov 13, 2024CMS CAMERON MCKENNA NABARRO OLSWANGADMISSIBLE
PORTA SOPHIAMay 22, 2024FLEUCHAUS & GALLO PARTNERSCHAFT MBBADMISSIBLE

Patent Citations (8) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONEP0933093
DESCRIPTIONEP1884254
DESCRIPTIONUS7458374
DESCRIPTIONUS9370629
DESCRIPTIONUS9687487
INTERNATIONAL-SEARCH-REPORTWO2018195455
INTERNATIONAL-SEARCH-REPORTWO2019081764
OTHERWO2019081764

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents